By: PCaSO DPO

25 SepProstate Cancer screening a little nearer?


On 21st September the EU Commission published an update, based on the latest scientific evidence, of the EU Council Screening Recommendations…

Read More

25 SepPCaSO donates £2,000 to “OutKick Cancer”


PCaSO has donated £2,000 to Sussex-based support charity Cancer United who provide a range of “CUFitter” exercise opportunities for people living…

Read More

25 SepProstate Cancer Research : new Podcast episodes


PCR (Prostate Cancer Research) have released new episodes of their useful Podcast series, covering subjects such as the risk impact of…

Read More

21 SepPCaSO on the BBC


On Saturday 3 September 2022, the BBC1 South Today TV programme ran as their headline item an article on PCaSO’s PSA...Read More

19 AugNew research to help prevent secondary (metastatic) bone tumours.


Prostate Cancer Research have been investigating how to prevent prostate cancer spreading to the bones as metastatic prostate cancer. Such tumours…

Read More

19 AugHormone (ADT) therapy side-effects trial


A new trial is investigating whether nurse-delivered cognitive behavioural therapy (CBT) can help reduce hot flushes and night sweats experienced by…

Read More

16 AugImmunotherapy update: useful talk at PCaSO AGM


PCaSO AGM 25 July 2022 (via Zoom). Notes from talk by Professor Edd James, University of Southampton. Professor James’ career has…

Read More

16 AugNew cancer-seeking “guided missiles”!


The Institute of Cancer Research, London, has welcomed the news that 177Lu-PSMA-617, a potent radioactive medicine has been approved by the…

Read More

04 AugNew Advanced Prostate Cancer Support Group (National)


Save the Date! September 26th from 18.00-19.30 Message from our colleagues at Tackle Prostate Cancer, about their new online support group…

Read More

29 JulWorthing Hospital: prostate cancer developments talk


On 16 June 2022 PCaSO’s Rustington Group welcomed Andrew Hart, one of two Oncology Nurse Specialists at Worthing Hospital. Our thanks…

Read More